Creative Medical Technology (CELZ) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.74, -9.39% vs the prior close of $0.82.
- Volume 168.50K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CELZ slides 9.4% to $0.74, a 1-month low. Closed at $0.74, -9.39% vs the prior close of $0.82. Day range $0.73–$0.85, opened at $0.84.
CELZ daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CELZ slides 9.4% to $0.74, a 1-month low
- Closed at $0.74, -9.39% vs the prior close of $0.82. Day range $0.73–$0.85, opened at $0.84.
- Volume was 168.50K shares, 0.0x its 50-day average of 7.74M — lighter than usual.
- Price is -28.0% vs its 50-day average ($1.03) and -55.0% vs its 200-day average ($1.65).
- 52-week range $0.62–$6.25; today's close sits at 2% of that range, 88.1% below the 52-week high.
Oct 15, 2026 — CELZ jumps 5.9% to $0.82
- Closed at $0.82, +5.89% vs the prior close of $0.77. Day range $0.76–$0.82, opened at $0.78.
- Volume was 63.10K shares, 0.0x its 50-day average of 8.60M — lighter than usual.
- Price is -21.1% vs its 50-day average ($1.04) and -50.5% vs its 200-day average ($1.65).
- 52-week range $0.62–$6.25; today's close sits at 4% of that range, 86.9% below the 52-week high.
Oct 14, 2026 — CELZ slides 5.8% to $0.77, a 1-month low
- Closed at $0.77, -5.81% vs the prior close of $0.82. Day range $0.76–$0.80, opened at $0.80.
- Volume was 167.40K shares, 0.0x its 50-day average of 8.60M — lighter than usual.
- Price is -25.3% vs its 50-day average ($1.03) and -53.4% vs its 200-day average ($1.66).
- 52-week range $0.62–$6.25; today's close sits at 3% of that range, 87.6% below the 52-week high.
Oct 13, 2026 — CELZ dips 2.5% to $0.82, a 1-month low
- Closed at $0.82, -2.51% vs the prior close of $0.84. Day range $0.81–$0.85, opened at $0.83.
- Volume was 56.90K shares, 0.0x its 50-day average of 8.60M — lighter than usual.
- Price is -20.5% vs its 50-day average ($1.03) and -50.7% vs its 200-day average ($1.66).
- 52-week range $0.62–$6.25; today's close sits at 4% of that range, 86.9% below the 52-week high.
Oct 12, 2026 — CELZ ends flat (+0.3%) to $0.84
- Closed at $0.84, +0.30% vs the prior close of $0.84. Day range $0.82–$0.87, opened at $0.83.
- Volume was 90.10K shares, 0.0x its 50-day average of 8.61M — lighter than usual.
- Price is -18.2% vs its 50-day average ($1.03) and -49.7% vs its 200-day average ($1.67).
- 52-week range $0.62–$6.25; today's close sits at 4% of that range, 86.5% below the 52-week high.
Oct 9, 2026 — CELZ dips 2.5% to $0.84, 5 down days in a row
- Closed at $0.84, -2.55% vs the prior close of $0.86. Day range $0.82–$0.88, opened at $0.86.
- Volume was 148.80K shares, 0.0x its 50-day average of 8.60M — lighter than usual.
- Price is -18.2% vs its 50-day average ($1.02) and -50.0% vs its 200-day average ($1.68).
- 52-week range $0.62–$6.25; today's close sits at 4% of that range, 86.6% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — CELZ slides 3.2% to $0.86, 4 down days in a row
- Closed at $0.86, -3.22% vs the prior close of $0.89. Day range $0.86–$0.89, opened at $0.88.
- Volume was 40.30K shares, 0.0x its 50-day average of 8.61M — lighter than usual.
- Price is -15.9% vs its 50-day average ($1.02) and -48.9% vs its 200-day average ($1.68).
- 52-week range $0.62–$6.25; today's close sits at 4% of that range, 86.2% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — CELZ dips 1.3% to $0.89, 3 down days in a row
- Closed at $0.89, -1.27% vs the prior close of $0.90. Day range $0.88–$0.91, opened at $0.91.
- Volume was 52.20K shares, 0.0x its 50-day average of 8.61M — lighter than usual.
- Price is -12.8% vs its 50-day average ($1.02) and -47.4% vs its 200-day average ($1.69).
- 52-week range $0.62–$6.25; today's close sits at 5% of that range, 85.8% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — CELZ dips 2.1% to $0.90
- Closed at $0.90, -2.13% vs the prior close of $0.92. Day range $0.89–$0.92, opened at $0.90.
- Volume was 70.10K shares, 0.0x its 50-day average of 8.61M — lighter than usual.
- Price is -11.5% vs its 50-day average ($1.02) and -46.9% vs its 200-day average ($1.70).
- 52-week range $0.62–$6.25; today's close sits at 5% of that range, 85.6% below the 52-week high.
Oct 5, 2026 — CELZ dips 2.8% to $0.92
- Closed at $0.92, -2.79% vs the prior close of $0.95. Day range $0.92–$0.96, opened at $0.96.
- Volume was 70.90K shares, 0.0x its 50-day average of 8.61M — lighter than usual.
- Price is -9.3% vs its 50-day average ($1.01) and -46.0% vs its 200-day average ($1.70).
- 52-week range $0.62–$6.25; today's close sits at 5% of that range, 85.3% below the 52-week high.
Oct 2, 2026 — CELZ rises 0.5% to $0.95
- Closed at $0.95, +0.50% vs the prior close of $0.94. Day range $0.92–$0.97, opened at $0.94.
- Volume was 89.50K shares, 0.0x its 50-day average of 8.62M — lighter than usual.
- Price is -6.5% vs its 50-day average ($1.01) and -44.6% vs its 200-day average ($1.71).
- 52-week range $0.62–$6.25; today's close sits at 6% of that range, 84.9% below the 52-week high.
CELZ latest news & SEC filings
Every SEC filing by or about CELZ in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Warbington Timothy & Creative Acquisition Corp. received an award of 1,000,000 shares on Sep 24, 2026; now holds 1,034,904
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Aug 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$1.51M (prior year -$1.23M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.41 (prior year -$0.48) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 31, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 24, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 14, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 1, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jun 26, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 25, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade CELZ
- How much it moves: over the last 20 sessions the average daily move was 3.37% (largest 9.4%). That is a volatile stock.
- Liquidity: about 1.22M shares (≈$905.64K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.74 vs a range of $0.62–$6.25 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 25, 2026; 8-K Aug 31, 2026; 10-Q Aug 7, 2026.
- Share count: 6.59M shares outstanding (Aug 7, 2026), +155.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
CELZ market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.84 | 0.85 | 0.73 | 0.74 | 168.50K |
| Oct 15, 2026 | 0.78 | 0.82 | 0.76 | 0.82 | 63.10K |
| Oct 14, 2026 | 0.80 | 0.80 | 0.76 | 0.77 | 167.40K |
| Oct 13, 2026 | 0.83 | 0.85 | 0.81 | 0.82 | 56.90K |
| Oct 12, 2026 | 0.83 | 0.87 | 0.82 | 0.84 | 90.10K |
| Oct 9, 2026 | 0.86 | 0.88 | 0.82 | 0.84 | 148.80K |
| Oct 8, 2026 | 0.88 | 0.89 | 0.86 | 0.86 | 40.30K |
| Oct 7, 2026 | 0.91 | 0.91 | 0.88 | 0.89 | 52.20K |
| Oct 6, 2026 | 0.90 | 0.92 | 0.89 | 0.90 | 70.10K |
| Oct 5, 2026 | 0.96 | 0.96 | 0.92 | 0.92 | 70.90K |
| Oct 2, 2026 | 0.94 | 0.97 | 0.92 | 0.95 | 89.50K |
| Oct 1, 2026 | 0.93 | 0.97 | 0.93 | 0.94 | 208.30K |
| Sep 30, 2026 | 0.93 | 0.98 | 0.88 | 0.93 | 98.10K |
| Sep 29, 2026 | 1.00 | 1.01 | 0.91 | 0.97 | 234.80K |
| Sep 28, 2026 | 1.00 | 1.04 | 0.98 | 1.01 | 213.80K |
| Sep 25, 2026 | 0.99 | 1.05 | 0.94 | 1.03 | 321.50K |
| Sep 24, 2026 | 0.95 | 0.99 | 0.92 | 0.97 | 200.70K |
| Sep 23, 2026 | 0.89 | 1.00 | 0.89 | 0.97 | 361.20K |
| Sep 22, 2026 | 0.88 | 0.96 | 0.80 | 0.94 | 1.78M |
| Sep 21, 2026 | 0.99 | 1.04 | 0.95 | 1.00 | 20.01M |
About Creative Medical Technology
Creative Medical Technology (CELZ) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in PHOENIX, AZ. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1187953.
CELZ board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Acquisition Corp. Creative | Director | Sep 25, 2026 |
| Timothy Warbington | President & CEO | Sep 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Timothy Warbington | President & CEO | Sep 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CELZ financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.00K | $-6.00M | -2.52 | $-5.86M |
| Dec 31, 2024 | $11.00K | $-5.49M | -3.71 | $-5.30M |
| Dec 31, 2023 | $9.00K | $-5.29M | -3.76 | $-8.03M |
| Dec 31, 2022 | $88.60K | $-10.14M | -0.93 | $-7.80M |
| Dec 31, 2021 | $87.75K | $19.21M | 5.61 | $-2.22M |
Latest balance sheet: total assets $9.38M, total liabilities $698.60K, cash $4.51M (as of Jun 30, 2026).
CELZ earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CELZ
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.